Details of Protein
| General Information of Protein (ID: PRT00266) | |||||
|---|---|---|---|---|---|
| Name | L-2-hydroxyglutarate dehydrogenase (L2HGDH) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
Duranin; L2hgdh
|
||||
| Gene Name | L2hgdh | Gene ID | |||
| UniProt ID | |||||
| Family | Oxidoreductases (EC 1) | ||||
| EC Number | EC: 1.1.99.2 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MWPTLRYVGGVCGLARYCVAGGFLRASGPASGVPGLLCGGGRRSSSTSSFDIVIVGGGIV
GLASARTLILKHPGLSIGVVEKEKDLALHQTGHNSGVIHSGIYYKPESLKAKLCVEGAAL IYEYCNLKGIPYRQCGKLIVAVEQEEIPRLQALYERGLQNGVEGLRLIQQEDIKKKEPYC RGLMAIDCPYTGIVNYQQVALSFAQDFQEAGGSILRDFEVKGIEIAKENSSRSKDGMNYP IAVKNSKGKEIRCRYVVTCAGLYSDRISELSGCNPDPQIVPFRGDYLVLKPEKGYLVKGN IYPVPDSRFPFLGVHFTPRLDGTIWLGPNAVLAFKREGYRPFDFDARDVMEVILKSGFIN LVFQHFSYGVNEMYKACFLSETVKHLQKFIPEITISDVLRGPAGVRAQALDRDGNLVEDF VFDGGTGEIADRVLHVRNAPSPAATSSLAISRMIAEEAQQRFKL |
||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | ||||||
| dCMP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | dCMP concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of dCMP levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| Alanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Alanine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of alanine levels compared with control group. | |||||
| Arginine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Arginine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of arginine levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Arginine concentration: increase (FC = 2.3) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the increase of arginine levels compared with control group. | |||||
| Asparagine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Asparagine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of asparagine levels compared with control group. | |||||
| Cysteine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Cysteine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of cysteine levels compared with control group. | |||||
| Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Glutamic acid concentration: decrease (FC= 0.78) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the decrease of glutamic acid levels compared with control group. | |||||
| Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Glutamine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glutamine levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Glutamine concentration: decrease (FC= 0.55) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the decrease of glutamine levels compared with control group. | |||||
| Glyceric acid 1,3-biphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Glyceric acid 1,3-biphosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glyceric acid 1,3-biphosphate levels compared with control group. | |||||
| Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Glycine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glycine levels compared with control group. | |||||
| Histidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Histidine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of histidine levels compared with control group. | |||||
| L-2-Hydroxyglutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | L-2-Hydroxyglutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the increase of L-2-hydroxyglutaric acid levels compared with control group. | |||||
| L-Homoserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | L-Homoserine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of L-homoserine levels compared with control group. | |||||
| Lysine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Lysine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of lysine levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Lysine concentration: increase (FC = 3.4) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the increase of lysine levels compared with control group. | |||||
| Malic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Malic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of malic acid levels compared with control group. | |||||
| Methionine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Methionine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of methionine levels compared with control group. | |||||
| N-Acetylglutamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | N-Acetylglutamine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of N-acetylglutamine levels compared with control group. | |||||
| Phenylalanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Phenylalanine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of phenylalanine levels compared with control group. | |||||
| Proline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Proline concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of proline levels compared with control group. | |||||
| Pyruvic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Pyruvic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of pyruvic acid levels compared with control group. | |||||
| Saccharopine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Saccharopine concentration: decrease (Decreased 100%) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the decrease of saccharopine levels compared with control group. | |||||
| Serine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Serine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of serine levels compared with control group. | |||||
| Threonine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Threonine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of threonine levels compared with control group. | |||||
| Valine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Valine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of valine levels compared with control group. | |||||
| Organic nitrogen compounds | ||||||
| Ethanolamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of L2hgdh | |||||
| Induced Change | Ethanolamine concentration: increase (FC = 1.7) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of L2hgdh leads to the increase of ethanolamine levels compared with control group. | |||||
| Organic oxygen compounds | ||||||
| Dihydroxyacetone phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Dihydroxyacetone phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of dihydroxyacetone phosphate levels compared with control group. | |||||
| Fructose 1,6-bisphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Fructose 1,6-bisphosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of fructose 1,6-bisphosphate levels compared with control group. | |||||
| Glyceraldehyde 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Glyceraldehyde 3-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glyceraldehyde 3-phosphate levels compared with control group. | |||||
| Glycerol | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Glycerol concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of glycerol levels compared with control group. | |||||
| Organoheterocyclic compounds | ||||||
| Tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
| Induced Change | Tryptophan concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Melanoma [ICD-11: 2C30] | |||||
| Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of tryptophan levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

